Skip to main content
Clinical Trials/IRCT20171030037093N28
IRCT20171030037093N28
Recruiting
Phase 3

Comparative study of therapeutic effect and side effects of enoxaparin with UFH in pregnant patients with mechanical prosthetic heart valves at their first 14 weeks of pregnancy

Esfahan University of Medical Sciences0 sites34 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pregnancy Outcome in Women with Mechanical Prosthetic Heart Valves.
Sponsor
Esfahan University of Medical Sciences
Enrollment
34
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • No drug allergy to any of the drugs studied
  • No history of recurrent miscarriage or stillbirth associated with antiphospholipid syndrome
  • Being monitored by the researcher from the beginning of pregnancy
  • Having Class I or II heart disease
  • Having a metal heart valve
  • Having a pregnancy week of 14 weeks or less

Exclusion Criteria

  • Non\-cooperation after inclusion
  • Lack of access to the patient and follow\-up
  • Forced to terminate pregnancy immediately
  • Warfarin use in the first 3 months
  • Patients not able to follow up anti\-10a factor
  • Thrombocytopenia (less than 75,000\)

Outcomes

Primary Outcomes

Not specified

Similar Trials